SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
ABRX ABLE LABS
An SI Board Since August 2003
Posts SubjectMarks Bans Symbol
9 1 0 ABRX
Emcee:  Tadsamillionaire Type:  Unmoderated
Introduction Market Data Compact
Able Laboratories, Inc. is a rapidly growing developer and manufacturer of generic pharmaceuticals in tablet, capsule and suppository dosage forms. Able's focus is to develop products that offer attractive market opportunities within selected niche markets of the generic drug industry. In addition to one New Drug Application approval (NDA), the Company received 31 Abbreviated New Drug Application approvals (ANDAs), and has several ANDAs pending FDA approval.
With a total commitment to quality and service, and a robust pipeline of new products in development, Able is strategically positioned to meet and exceed the needs and expectations of its customers and the consumer.
ablelabs.com
 Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
9Able Laboratories, Inc. and Strides, Inc. Announce the Signing of a Development Tadsamillionaire-12/2/2004
8Able Laboratories Will Present at The CIBC Fifteenth Annual Healthcare ConferencTadsamillionaire-11/10/2004
7ThanksTadsamillionaire-6/8/2004
6Research Update (ABRX) biotechstocksignals.com The original report on ABRX canTom Ronk-6/8/2004
5Able Laboratories Signs Long-Term Lease for a 225,000 Square Foot Facility WedneTadsamillionaire-9/29/2003
4Able Laboratories Receives FDA Approval for Naproxen Sodium Tablets, USP 275 mg Tadsamillionaire-9/29/2003
3Able Laboratories Receives FDA Approval for Butalbital Acetaminophen Caffeine AnTadsamillionaire-8/22/2003
2CBOE Lists Options on Able Laboratories Common Stock Monday August 4, 11:59 am ETadsamillionaire-8/19/2003
1Able Laboratories Inc. Earnings Conference Call (Q2 2003) Mon, Jul 28, 2003, 10:Tadsamillionaire-8/1/2003
 Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News